Terns Pharmaceuticals
@TernsPharma
Followers
314
Following
2
Media
337
Statuses
420
Reimaging known biology to deliver high impact medicines
Foster City, CA
Joined January 2019
Next week, we’ll join peers at #ASH25 to explore advances in hematologic disorders, including chronic myeloid leukemia (CML), a blood cancer that begins in the bone marrow. Explore the program: https://t.co/IZB07fUoHW
0
0
1
Our team came together for our seasonal event, “Autumn in the City,” to celebrate another year of progress, collaboration, and purpose. We’re grateful for our dedicated team and partners who continue to advance our mission of improving the lives of people with serious diseases.
0
0
0
Today we announced our third quarter 2025 financial results and provided an update on the progress of our development programs. Read the full press release here: https://t.co/mBMUrZcRZG
0
0
0
We’ve joined @CALifeSciences, a community advancing innovation across biotech, therapeutics, and #medtech. We look forward to contributing and collaborating to support discovery and patient impact in our local communities!
0
0
0
We’re pleased to share that our abstract from our allosteric BCR::ABL1 inhibitor program for chronic myeloid leukemia (CML) has been selected for an oral presentation at #ASH25. See our press release for details: https://t.co/iSXE0UA6xG
@ASH_hematology
0
1
3
Happy Halloween from Terns! Our team celebrated with sweet treats, pumpkin painting, team bonding, and a bit of friendly competition during our costume contest, showcasing the creativity and spirit that make our team so special.
0
0
0
Our CMO, Emil Kuriakose, MD, joined @DrugDiscovNews to explore the evolving treatment landscape for #CML, highlighting next-generation allosteric therapies and the potential benefits they offer for patients living with this chronic condition: https://t.co/VP4wy4EoY3
0
0
1
#ICYMI: Our CEO Amy Burroughs joined @PharmaPhorum’s podcast for a discussion on our chronic myeloid leukemia (#CML) development program, with insights on the broader #oncology treatment landscape. Listen to the full episode here: https://t.co/1THS28UUAH
0
1
3
The @LLSusa has reintroduced itself as Blood Cancer United, reflecting its mission to serve all people impacted by blood cancers. At Terns, we are proud to contribute through our research in #CML. Visit their website to learn more: https://t.co/woUwARzHSN
0
0
1
We’re in Portugal for the 27th Annual John Goldman Conference on #CML. Our team is presenting two encore posters on preclinical and clinical pharmacology studies, contributing to collaboration and scientific exchange in the global CML community. #ESHCML2025
0
0
4
Next week #ESHCML2025 begins in Portugal. Our team will present two encore posters that add to the scientific dialogue & advance understanding of CML biology. Learn more: https://t.co/p4rwgWZwrP
0
0
1
As Blood Cancer Awareness Month concludes, we remain committed to advancing therapies for chronic myeloid #leukemia and supporting the patients we serve. Learn more: https://t.co/7V0ccYxDg1
0
1
3
The @icmlf provides a valuable platform for individuals living with chronic myeloid #leukemia to connect, access expert knowledge, and find support in community. Learn more: https://t.co/5KkCzHUR9z
#BloodCancerAwarenessMonth
0
2
3
Thank you to @PharmaPhorum’s @NicoleRaleighpp for interviewing our CEO Amy Burroughs about our allosteric BCRABL program for chronic myeloid #leukemia and the preclinical data we presented at #EHA2025. Listen here:
pharmaphorum.com
0
1
2
In honor of #WorldCMLDay, we’re joining @cmlnet to raise awareness of chronic myeloid #leukemia, support those living with CML, and advocate for continued progress in treatment and care, ensuring that no patient is left behind. Learn more: https://t.co/X0j8wcJTsN
#WCMLD25
0
1
4
Missed our CML webinar? Our leadership team shared insights on our investigational next-gen oral, allosteric BCR-ABL inhibitor and the evolving CML landscape. Watch the recording here: https://t.co/ZheZybhcM7
0
0
1
Today our team is participating in a virtual #firesidechat with @UBS. We look forward to engaging in meaningful conversations and discussing our #oncology and #obesity development programs.
0
0
1
Join our team today at 10:00 a.m. ET for a #firesidechat during the @MorganStanley 23rd Annual Global Healthcare Conference in New York. A live webcast and #replay will be available on our website at https://t.co/Fty4EieNW1.
0
0
1
Heather Turner, J.D., a member of our Board of Directors, was recently featured in @BioSpace highlighting the leadership of women shaping the future of #biopharma. We’re proud to have Heather’s expertise guiding our mission at Terns.
biospace.com
Some of the most high-profile acquisitions in recent years have involved women-fronted biotechs. BioSpace reviews five of the most notable here.
0
0
1
Next Wednesday, September 10, at 10 a.m. ET, our team will participate in a #firesidechat during the @MorganStanley 23rd Annual Global Healthcare Conference in New York to discuss our #oncology and #obesity development programs. For details: https://t.co/Fty4EieNW1.
#MSHealthcare
0
0
1